Anti-FAM189B monoclonal antibody

Pre-made anti-FAM189B monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to FAM189B/FAM189B products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0812-Ab-1/ GM-Tg-hg-IP0812-Ab-2Anti-Human FAM189B monoclonal antibodyHuman
GM-Tg-rg-IP0812-Ab-1/ GM-Tg-rg-IP0812-Ab-2Anti-Rat FAM189B monoclonal antibodyRat
GM-Tg-mg-IP0812-Ab-1/ GM-Tg-mg-IP0812-Ab-2Anti-Mouse FAM189B monoclonal antibodyMouse
GM-Tg-cynog-IP0812-Ab-1/ GM-Tg-cynog-IP0812-Ab-2Anti-Cynomolgus/ Rhesus macaque FAM189B monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0812-Ab-1/ GM-Tg-felg-IP0812-Ab-2Anti-Feline FAM189B monoclonal antibodyFeline
GM-Tg-cang-IP0812-Ab-1/ GM-Tg-cang-IP0812-Ab-2Anti-Canine FAM189B monoclonal antibodyCanine
GM-Tg-bovg-IP0812-Ab-1/ GM-Tg-bovg-IP0812-Ab-2Anti-Bovine FAM189B monoclonal antibodyBovine
GM-Tg-equg-IP0812-Ab-1/ GM-Tg-equg-IP0812-Ab-2Anti-Equine FAM189B monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0812-Ab-1/ GM-Tg-hg-IP0812-Ab-2; GM-Tg-rg-IP0812-Ab-1/ GM-Tg-rg-IP0812-Ab-2;
GM-Tg-mg-IP0812-Ab-1/ GM-Tg-mg-IP0812-Ab-2; GM-Tg-cynog-IP0812-Ab-1/ GM-Tg-cynog-IP0812-Ab-2;
GM-Tg-felg-IP0812-Ab-1/ GM-Tg-felg-IP0812-Ab-2; GM-Tg-cang-IP0812-Ab-1/ GM-Tg-cang-IP0812-Ab-2;
GM-Tg-bovg-IP0812-Ab-1/ GM-Tg-bovg-IP0812-Ab-2; GM-Tg-equg-IP0812-Ab-1/ GM-Tg-equg-IP0812-Ab-2
Products NameAnti-FAM189B monoclonal antibody
Formatmab
Target NameFAM189B
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-FAM189B monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0812-Ag-1Recombinant multi-species F189B/ FAM189B/ C1orf2 protein


    Target information

    Target IDGM-IP0812
    Target NameFAM189B
    Gene ID10712,68521,310640,719116,490428,101088978,100300734,100057304
    Gene Symbol and Synonyms1110013L07Rik,C1orf2,COTE1,ENTREP3,FAM189B,RGD1306107
    Uniprot AccessionP81408
    Uniprot Entry NameF189B_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000160767
    Target ClassificationN/A

    The target: FAM189B, gene name: FAM189B, also named as C1orf2, COTE1. This gene is located near the gene for the lysosomal enzyme glucosylceramidase; a deficiency in this enzyme is associated with Gaucher disease. The encoded protein has been identified as a potential binding partner of a WW domain-containing protein which is involved in apoptosis and tumor suppression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.